Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TREH | O43280 | 1/20 | 0.42 |
| ▸ | PYGB | P11216 | 7/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.36 |
| ▸ | OGA | O60502 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL181299 | 1.00 | TREH (0.42) | TREHPYGBGAALGALS3OGA | |
| SCHEMBL14653765 | 1.00 | TREH (0.42) | TREHPYGBGAALGALS3OGA | |
| SCHEMBL20001791 | 1.00 | TREH (0.42) | TREHPYGBGAALGALS3OGA | |
| SCHEMBL18391236 | 0.87 | TREH (0.43) | TREHPYGBGAALGALS3OGA | |
| SCHEMBL24701843 | 0.84 | TREH (0.42) | TREHPYGBGAALGALS3OGA | |
| SCHEMBL24239887 | 0.84 | PYGB (0.54) | TREHPYGBGAALGALS3OGA | |
| SCHEMBL15806345 | 0.84 | PYGB (0.54) | TREHPYGBGAALGALS3 | |
| SCHEMBL15504388 | 0.84 | PYGB (0.54) | TREHPYGBGAALGALS3OGA | |
| SCHEMBL30980791 | 0.83 | ASGR1 (0.42) | TREHPYGBGAALGALS3 | |
| SCHEMBL23705059 | 0.81 | TREH (0.44) | TREHPYGBGAALGALS3OGA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6204029-B1 | MIXTURE OF ACTIVATED GLYCOSIDE DERIVITIVE, MUTANT GLYCOSYLTRANSFERASE, ACCEPTOR SUBSTRATE, AND NUCLEOTIDE PHOSPHATE OR ANALOG | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-03-20 | — | — | US | claimed |
| EP-0973932-A1 | IMPROVED SYNTHESIS OF OLIGOSACCHARIDES USING ACTIVATED GLYCOSIDE DERIVATIVES | UNIVERSITY OF BRITISH COLUMBIA (CA) | 2000-01-26 | — | — | EP | claimed |
| US-5952203-A | Oligosaccharide synthesis using activated glycoside derivative, glycosyl transferase and catalytic amount of nucleotide phosphate | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 1999-09-14 | — | — | US | claimed |
| WO-1998046784-A1 | IMPROVED SYNTHESIS OF OLIGOSACCHARIDES USING ACTIVATED GLYCOSIDE DERIVATIVES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 1998-10-22 | — | — | WO | claimed |
| US-20230058309-A1 | SERUM AMYLOID P DERIVATIVES AND THEIR PREPARATION AND USE | PROMEDIOR INC (US) | 2023-02-23 | — | — | US | disclosed |
| US-20210322515-A1 | METHODS FOR TREATING FIBROTIC CANCERS | PROMEDIOR INC (US) | 2021-10-21 | — | — | US | disclosed |
| US-20210179679-A1 | SERUM AMYLOID P DERIVATIVES AND THEIR PREPARATION AND USE | PROMEDIOR INC (US) | 2021-06-17 | — | — | US | disclosed |
| US-11020451-B2 | Methods for treating fibrotic cancers | PROMEDIOR, INC. (US) | 2021-06-01 | — | — | US | disclosed |
| US-20200369735-A1 | SERUM AMYLOID P DERIVATIVES AND THEIR PREPARATION AND USE | PROMEDIOR INC (US) | 2020-11-26 | — | — | US | disclosed |
| EP-3718558-A1 | METHODS FOR TREATING FIBROTIC CANCERS | Promedior, Inc. (US) | 2020-10-07 | — | — | EP | disclosed |
| EP-2347003-B1 | GALACTOSE ALPHA (1-3) GALACTOSE COMPOSITIONS | JANSSEN BIOTECH INC (US) | 2020-06-10 | — | — | EP | disclosed |
| US-20180318303-A1 | METHODS FOR TREATING MYELOPROLIFERATIVE DISORDERS | PROMEDIOR, INC. | 2018-11-08 | — | — | US | disclosed |
| WO-2003045980-A2 | GLYCOPEPTIDE REMODELING USING AMIDASES | NEOSE TECHNOLOGIES, INC. (US) | 2003-06-05 | — | — | WO | disclosed |
| WO-2003031464-A2 | REMODELING AND GLYCOCONJUGATION OF PEPTIDES | NEOSE TECHNOLOGIES, INC. (US) | 2003-04-17 | — | — | WO | disclosed |
| WO-2003016469-A2 | CHEMO-ENZYMATIC SYNTHESIS OF SIALYLATED OLIGOSACCHARIDES | NEOSE TECHNOLOGIES, INC. (US) | 2003-02-27 | — | — | WO | disclosed |
| WO-2003011879-A1 | NEUTRAL GLYCOSPHINGOLIPIDS AND GLYCOSYL-SPHINGOSINES AND METHODS FOR ISOLATING THE SAME | NEOSE TECHNOLOGIES, INC. (US) | 2003-02-13 | — | — | WO | disclosed |
| US-6204029-B1 | MIXTURE OF ACTIVATED GLYCOSIDE DERIVITIVE, MUTANT GLYCOSYLTRANSFERASE, ACCEPTOR SUBSTRATE, AND NUCLEOTIDE PHOSPHATE OR ANALOG | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-03-20 | — | — | US | disclosed |
| EP-0973932-A1 | IMPROVED SYNTHESIS OF OLIGOSACCHARIDES USING ACTIVATED GLYCOSIDE DERIVATIVES | UNIVERSITY OF BRITISH COLUMBIA (CA) | 2000-01-26 | — | — | EP | disclosed |
| US-5952203-A | Oligosaccharide synthesis using activated glycoside derivative, glycosyl transferase and catalytic amount of nucleotide phosphate | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 1999-09-14 | — | — | US | disclosed |
| WO-1998046784-A1 | IMPROVED SYNTHESIS OF OLIGOSACCHARIDES USING ACTIVATED GLYCOSIDE DERIVATIVES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 1998-10-22 | — | — | WO | disclosed |